A detailed history of Jump Financial, LLC transactions in Savara Inc stock. As of the latest transaction made, Jump Financial, LLC holds 20,755 shares of SVRA stock, worth $52,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,755
Holding current value
$52,717
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$2.94 - $4.07 $61,019 - $84,472
20,755 New
20,755 $63,000
Q1 2024

May 13, 2024

SELL
$4.19 - $5.59 $305,132 - $407,086
-72,824 Reduced 53.27%
63,876 $318,000
Q4 2023

Oct 21, 2024

BUY
$3.18 - $4.9 $331,273 - $510,452
104,174 Added 320.28%
136,700 $642,000
Q4 2023

Feb 07, 2024

BUY
$3.18 - $4.9 $331,273 - $510,452
104,174 Added 320.28%
136,700 $642,000
Q3 2023

Oct 21, 2024

BUY
$2.97 - $3.88 $96,602 - $126,200
32,526 New
32,526 $122,000
Q3 2023

Nov 07, 2023

BUY
$2.97 - $3.88 $96,602 - $126,200
32,526 New
32,526 $122,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $290M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.